Tissue & cell · 2026
Molecular insights into Pterygium: The emerging role of microRNAs in pathogenesis and therapeutic potential.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alamri Abdulrahman
Аннотация
PURPOSE: Pterygium is a common ocular surface disorder, particularly prevalent in tropical regions, that can lead to visual impairment and ocular discomfort. Understanding the molecular mechanisms involved in Pterygium formation is crucial for improving outcomes and reducing recurrence. The objective of this study was to elucidate the key microRNAs (miRNAs) and molecular pathways involved in the pathogenesis of Pterygium.
METHODS: This study investigates the molecular mechanisms underlying the disease and the function of microRNAs in its onset, progression, and therapy by analyzing credible scientific databases and the associated literature.
RESULTS: Several miRNAs (such as the miR-200 family) have been associated with the development and clinical severity of Pterygium through mechanisms involving cell proliferation, apoptosis, IL-17 signaling, insulin-like growth factor binding protein-2 (IGFBP-2), and epithelial-mesenchymal transition (EMT).
CONCLUSIONS: understanding the molecular pathways associated with Pterygium may facilitate the identification of potential preventive strategies and therapeutic targets, although further validation is required before clinical application.
METHODS: This study investigates the molecular mechanisms underlying the disease and the function of microRNAs in its onset, progression, and therapy by analyzing credible scientific databases and the associated literature.
RESULTS: Several miRNAs (such as the miR-200 family) have been associated with the development and clinical severity of Pterygium through mechanisms involving cell proliferation, apoptosis, IL-17 signaling, insulin-like growth factor binding protein-2 (IGFBP-2), and epithelial-mesenchymal transition (EMT).
CONCLUSIONS: understanding the molecular pathways associated with Pterygium may facilitate the identification of potential preventive strategies and therapeutic targets, although further validation is required before clinical application.